Article
Deficiency of adenosine deaminase 2 (DADA2): Review.
Best practice & research. Clinical rheumatology - 1 Mar 2023
Sharma Vikas, Deo Prateek, Sharma Aman
Abstract excerpt
The deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive disease caused by loss-of-function (LOF) mutations in the ADA2 gene and was first described in 2014. Initially, it was described as vasculopathy/vasculitis that mostly affected infants and young children and closely resembled polyarteritis nodosa (PAN). Skin rash and ischemic/hemorrhagic stroke are predominant symptoms. However, the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
